Featured Research

from universities, journals, and other organizations

Prostate Cancer Uses Wnt Signaling Proteins To Promote Growth Of Bone Tumors

Date:
September 7, 2005
Source:
University of Michigan Health System
Summary:
Prostate cancer cells often metastasize, or spread, to bone where they form tumors that are extremely painful. New research by U-M scientists shows that prostate cancer manipulates an important group of signaling proteins called Wnts to establish itself in bone.

ANN ARBOR, Mich. -- Prostate cancer is a cruel disease. Left untreated,prostate cancer cells often metastasize, or spread, to bone where theyform fracture-prone tumors that are extremely painful.

Related Articles


More than 80 percent of men who die from prostate cancer die withmetastatic disease in their bones. But scientists know very littleabout how migrating prostate cancer cells set up housekeeping in bonetissue and produce the dense bony lesions characteristic of prostatecancer.

Now, new research by scientists at the University of Michigan'sComprehensive Cancer Center suggests that prostate cancer manipulatesan important group of signaling proteins called Wnts (pronounced"wints") to establish itself in bone. By changing the amount andactivity of Wnt proteins, prostate cancer cells upset the normalbalance between formation and destruction of bony tissue.

"There is strong evidence that Wnt proteins play a centralrole in regulating normal skeletal development in an embryo," saysChristopher L. Hall, Ph.D., a senior research fellow in urology at U-M."But this is the first time Wnts have been shown to be involved inabnormal bone production in adult animals with prostate cancer."

Hall is first author of a paper to be published in the Sept. 1issue of Cancer Research, which presents results from U-M studies ofWnt proteins in human prostate cancer cell lines and in laboratory miceinjected with prostate cancer cells.

"Normal bone growth and remodeling depends on a controlledbalance between production of new bone and resorption of existingbone," says Evan T. Keller, D.V.M., Ph.D., a professor of urology andpathology in the U-M Medical School, who directed the U-M study. "Whena tumor forms in bone, it upsets this balance."

Several types of cancer metastasize to bone, according toKeller, but most of them tip the balance toward destruction --producing what scientists call osteolytic lesions, or holes in thebone. Prostate cancer is unique in its ability to trigger increasedbone production, which creates what's called an osteoblastic lesion.

"In metastatic prostate cancer, we think that both processesare going on," Keller says. "Our hypothesis is that prostate cancercells first induce more bone resorption to help the invading cellsbecome established in bone. But then there's a switch to increased boneproduction. Although we don't know the exact mechanism responsible forthe switch, we know that it's related to the activity of Wnt proteinsin prostate cancer cells."

In the first phase of their research, U-M scientists measuredthe amount of Wnt protein in cells from normal human prostate tissue,localized prostate cancer and metastatic prostate cancer cells. Usingthe same cell lines, they also looked for the presence of a proteincalled DKK-1, which is known to inhibit Wnt activity. They discoveredthat the amounts of Wnt and DKK-1 protein present in human prostatecells varied inversely with the developmental stage of prostate cancer.

"As the cancer progressed, DKK-1 levels went down," Hall says."Cells with osteoblastic activity had high levels of Wnt activity andlow levels of DKK-1, while cells with osteolytic activity showeddecreased Wnt activity and high levels of DKK-1."

"Our results suggest that DKK-1 may act like a switch onprostate cancer cell activity," Keller says. "When we altered the cellsto increase the amount of active DKK-1, it blocked Wnt's signal,changing prostate cancer cells from an osteoblastic to a highlyosteolytic cell line."

To test their hypothesis, U-M scientists injected humanprostate cancer cells into the tibias, or long leg bones, of one groupof immune-deficient mice. Twelve weeks later, U-M researchers removedand examined bone tumors from the mice. They found that these miceproduced tumors with a dense overgrowth of bone. A second group ofmice, injected with prostate cancer cells made to express the Wntinhibitor, DKK-1, developed highly osteolytic tumor lesions, whichdestroyed most of the bone.

"This demonstrated that Wnts promote the overproduction of bone by prostate cancer cells," Keller says.

In previous research, the U-M team found that preventing theosteolytic changes associated with bone resorption also preventedprostate cancer from establishing itself in bone. By learning how DKK-1blocks Wnt's signal to prostate cancer cells, they hope to learn how tocontrol physical changes in bone that encourage the development ofmetastatic tumors.

"Our goal is to find ways to manipulate this Wnt pathway toslow the growth of tumors in bone or decrease the tumor-associatedpain," Keller says. "We won't be able to stop the primary tumor fromreleasing cells, but by preventing early bone resorption, we may beable to prevent metastatic cells from getting a foothold in bone."

In future research, U-M scientists will try to identify whichof the nearly 20 known Wnt proteins is involved in bone changesassociated with metastatic prostate cancer.

###

The research was supportedby the National Cancer Institute. U-M research investigator Jinlu Dai,M.D., Ph.D., was a collaborator on the research study, along with AnnaBafico, Ph.D., and Stuart A. Aaronson, M.D., from the Mount SinaiComprehensive Cancer Center.

Cancer Research: 65 (17), September 1, 2005.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Michigan Health System. "Prostate Cancer Uses Wnt Signaling Proteins To Promote Growth Of Bone Tumors." ScienceDaily. ScienceDaily, 7 September 2005. <www.sciencedaily.com/releases/2005/09/050906075108.htm>.
University of Michigan Health System. (2005, September 7). Prostate Cancer Uses Wnt Signaling Proteins To Promote Growth Of Bone Tumors. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2005/09/050906075108.htm
University of Michigan Health System. "Prostate Cancer Uses Wnt Signaling Proteins To Promote Growth Of Bone Tumors." ScienceDaily. www.sciencedaily.com/releases/2005/09/050906075108.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins